Amarin Corporation plc | FinOracle
Amarin Corporation plc | FinOracle
Amarin Corporation plc | FinOracle
Amarin Corporation plc | FinOracle
Amarin Corporation plc | FinOracle
Amarin Corporation plc | FinOracle
Amarin Corporation plc | FinOracle
Amarin Corporation plc | FinOracle
Amarin Corporation plc | FinOracle
Amarin Corporation plc | FinOracle
Amarin Corporation plc | FinOracle
Amarin Corporation plc | FinOracle
Amarin Corporation plc | FinOracle
Amarin Corporation plc | FinOracle
Amarin Corporation plc | FinOracle
Amarin Corporation plc | FinOracle
Amarin Corporation plc | FinOracle
Amarin Corporation plc | FinOracle
Amarin Corporation plc | FinOracle
Amarin Corporation plc | FinOracle
Amarin Corporation plc | FinOracle
Amarin Corporation plc | FinOracle
Amarin Corporation plc | FinOracle
Amarin Corporation plc | FinOracle
Amarin Corporation plc | FinOracle
Amarin Corporation plc | FinOracle
Amarin Corporation plc | FinOracle
Amarin Corporation plc | FinOracle
Amarin Corporation plc | FinOracle
Amarin Corporation plc | FinOracle

Amarin Corporation plc

Symbol: (NASDAQ:AMRN)

Amarin Corporation Plc is a pharmaceutical company specializing in the development and commercialization of therapeutics for cardiovascular diseases. With a focus on the treatment of high triglyceride levels, Amarin is at the forefront of providing innovative solutions with their leading product, Vascepa. The company’s commitment to scientific research and dedication to improving patients’ lives sets them apart in the pharmaceutical industry.

Latest News

No Content Available

Welcome Back!

Login to your account below

Create New Account!

Fill the forms bellow to register

Retrieve your password

Please enter your username or email address to reset your password.

Home
Trends
Premium
Favorite
Account
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?